Dallas County Reports 335 New COVID-19 Cases, Four More Deaths

As local officials continue to monitor a recent uptick in COVID-19 cases and hospitalizations, we get closer to Election Day, and the deadline for filling out the Census nears, here’s what you need to know today:

  • Dallas County reports 335 new COVID-19 cases, four more deaths;
  • Johnson & Johnson pauses COVID-19 vaccine trials after ‘unexplained illness’;
  • High school students organize Census block walk with Dallas County Counts ahead of Oct. 31 deadline.
Dallas County Reports 335 New COVID-19 Cases, Four More Deaths

Dallas County Health and Human Services Monday reported 336 additional cases of COVID-19, as well as an additional four deaths for a cumulative total of 86,775 confirmed cases, and 1,056 confirmed deaths. 

There was one additional probable case reported Monday for a total of 4,342 probable cases including 13 probable deaths.

Of the 335 new confirmed cases reported Monday, 193 came through the Texas Department of State Health Services’ (DSHS) electronic laboratory reporting (ELR) system, and all are considered new cases. 

The additional deaths reported Monday include a Mesquite man in his 40s who didn’t have underlying health conditions, a Dallas woman in her 60s, a Garland man in his 80s who didn’t have underlying conditions, and a Mesquite woman in her 90s. Unless otherwise noted, they had underlying health conditions.

Of the total confirmed deaths reported to date, about 24% have been associated with long-term care facilities.

“Among today’s four deaths includes a man in his 40’s who did not have underlying high-risk health conditions,” said Dallas County Judge Clay Jenkins Monday. “We are seeing an uptick in cases and hospitalizations and the decisions that you make today will determine how we are doing ten days to two weeks from now. Let’s all wear our mask, maintain six-foot distance, and use good hand washing.

“Make your Halloween plans with your family and abstain from traditional trick-or-treating, parties, or trunk-or-treating. It’s up to all of us to flatten the curve. We must focus on community health and not our own desires to do the few things that doctors tell us remain unsafe.”

A provisional total of 265 confirmed and probable COVID-19 cases were diagnosed in school-aged children (5 to 17 years) during the week ending Oct. 3, an increase from the previous week in this age group. 

Highland Park ISD reported one case the week ending Sept. 5, seven cases the week ending Sept. 12, and 23 the week ending Sept. 19, according to Dallas County Health and Human Services’ Oct. 9 COVID-19 summary report.

Dallas ISD reported 55 cases the week ending Sept. 5, 48 the week ending Sept. 12, and 91 the week ending Sept. 19.

Twelve cases were reported in private schools in Dallas County the week ending Sept. 5, 19 the week ending Sept. 12, and one case the week ending Sept. 19.

Of all confirmed cases requiring hospitalization to date, more than two-thirds have been under 65 years of age. 

The percentage of respiratory specimens testing positive for the virus that causes COVID-19 also remains high, the county says, with 9.8% of symptomatic patients presenting to area hospitals testing positive in the week ending Oct. 3.

UT Southwestern Medical Center’s latest data also shows hospitalizations are on the rise again in North Texas.

UTSW also notes both hospitalizations and the number of patients in the ICU are expected to increase in both Dallas and Tarrant Counties over the next two weeks.

UTSW’s latest model projects total COVID-19 hospitalizations could increase to between 270 and 540 concurrent hospitalized cases by Oct. 23, and roughly 950 new COVID-19 infections per day are expected by Oct. 23.

Johnson & Johnson Pauses COVID-19 Vaccine Trials After ‘Unexplained Illness’

Johnson & Johnson officials announced Monday that they paused further dosing in all clinical trials of their experimental COVID-19 vaccine because of an unexplained illness in a study participant.

“Following our guidelines, the participant’s illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board (DSMB) as well as our internal clinical and safety physicians,” the company said in a statement. 

The company didn’t release more information about the participant, citing privacy concerns, but said they’re working to learn more about the participant’s illness.

Johnson & Johnson noted that illnesses and/or side effects are an expected part of any clinical study and there are prespecified guidelines in place for those events.

The guidelines ensure “studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study.”

The drugmaker also noted there’s a “significant distinction” between a study pause and a regulatory hold of a clinical trial.

“A study pause, in which recruitment or dosing is paused by the study sponsor, is a standard component of a clinical trial protocol,” the company noted.

The Wall Street Journal reported Johnson & Johnson’s vaccine is one of the most advanced COVID-19 vaccines in development, among a handful that had entered the last stage of testing in the U.S., after entrants from AstraZeneca, Moderna Inc., and Pfizer Inc.

AstraZeneca’s trials also were paused after a woman in a U.K. study of their vaccine had an unexplained illness, which a U.S. health official described as a spinal-cord problem, the WSJ reports.

The WSJ reports U.K. authorities allowed the U.K. trial to resume in September. Trials have resumed in several other countries including, Japan and Brazil, but the U.S. trial remains paused while AstraZeneca works with the Food and Drug Administration in reviewing the information needed to make a decision regarding resumption of the trial, the newspaper reported.

High School Students Organize Census Block Walk With Dallas County Counts Ahead of Oct. 31 Deadline

As the October 31 deadline for self-reporting approaches, a group of about 50 civic-minded teenagers, led by the nonprofit organization The Concilio, partnered with Dallas County Counts to block walk on October 3 and remind people to fill out the Census. 

 Alexis Velasco (International Leadership of Texas), Neha Dhanekula (Booker T. Washington), and Leslie Zarazua (Booker T. Washington). Photo:  Simon Luna

The teenagers fanned out across Pleasant Grove, Bachman Lake, and Northeast Dallas, where self-reporting numbers remain behind local and national averages. Over the course of three hours, they knocked on more than 500 doors to spread the message about the importance of the 2020 U.S. Census.

 “We want to make sure everyone counts, particularly in these underrepresented neighborhoods. The Census numbers determine funding for schools, roads, hospitals and services as well as congressional representation for Texans to thrive for the next decade,” said Florencia Velasco Fortner, The Concilio president and CEO.

For those needing to fill out the Census, go online at https://my2020census.gov/ or over the phone in English by dialing 844-330-2020 or in Spanish at 844-468-2020.

Rachel Snyder

Rachel Snyder, deputy editor at People Newspapers, joined the staff in 2019, returning to her native Dallas-Fort Worth after starting her career at community newspapers in Oklahoma. One of her stories won first place in its category in the Oklahoma Press Association’s Better Newspaper Contest in 2018. She’s a fan of puns and community journalism, not necessarily in that order. You can reach her at rachel.snyder@peoplenewspapers.com

Leave a Reply

Your email address will not be published. Required fields are marked *